Tenon Medical, Inc.
Canonical company identity and public leadership record.
- Source reported. 28 claims from 3 sources.
- Not claimed by the company.
- Eval: not assessed.
- Chair
- Not published
- Board
- 7 directorsAlpha calculation. Published seats
- Independence
- 4 of 7Alpha calculation
- Committees
- 6
- Evidence
- 3 sources28 published claims
- Open conflicts
- 0None open
Leadership
5 claims| Person | Role | Since | Status | Evidence |
|---|---|---|---|---|
| Kevin Williamson | Chief Financial Officer and Secretary | Current | Source reportedE3 | |
| Nathaniel Grawey | Chief Commercial Officer | Current | Source reportedE4 | |
| Richard Ginn | Chief Technology Officer and Chief Operations Officer | Current | Source reportedE5 | |
| Steven M. Foster | Chief Executive Officer and President | Current | Source reportedE6 | |
| Wyatt Geist | Chief Innovation Officer | Current | Source reportedE7 |
Board
7 claims| Director | Status | Since | Committees | Evidence |
|---|---|---|---|---|
| Ivan Howard | Independent | Audit, chair; Audit · Chair; Compensation; Nominating and Governance; Compensation; Nominating and Governance | Source reportedE2 | |
| Kristine M. Jacques | Independent | Audit; Audit; Compensation; Compensation | Source reportedE2 | |
| Richard Ferrari | Not independent | None published | Source reportedE2 | |
| Richard Ginn | Not independent | None published | Source reportedE2 | |
| Robert K. Weigle | Independent | Audit; Audit; Compensation; Nominating and Governance · Chair; Compensation; Nominating and Governance, chair | Source reportedE2 | |
| Stephen H. Hochschuler, M.D. | Independent | None published | Source reportedE2 | |
| Steven M. Foster | Not independent | None published | Source reportedE2 |
Committees
11 claims| Committee | Chair | Members | Risks assigned | Evidence |
|---|---|---|---|---|
| Audit | Ivan Howard | Ivan Howard, Kristine M. Jacques, Robert K. Weigle | Not described in the published record | Source reportedE8 |
| Audit · Chair; Compensation; Nominating and Governance | Not published | Ivan Howard | Not described in the published record | |
| Audit; Compensation | Not published | Kristine M. Jacques | Not described in the published record | |
| Audit; Compensation; Nominating and Governance · Chair | Not published | Robert K. Weigle | Not described in the published record | |
| Compensation | Not published | Ivan Howard, Kristine M. Jacques, Robert K. Weigle | Not described in the published record | Source reportedE8 |
| Nominating and Governance | Robert K. Weigle | Robert K. Weigle, Ivan Howard | Not described in the published record | Source reportedE8 |
| Fact | Stated value | Evidence |
|---|---|---|
| Committee appointment | Ivan Howard: chair, Audit | Source reportedE8 |
| Committee appointment | Kristine M. Jacques: member, Audit | Source reportedE8 |
| Committee appointment | Robert K. Weigle: member, Audit | Source reportedE8 |
| Committee appointment | Ivan Howard: member, Compensation | Source reportedE8 |
| Committee appointment | Kristine M. Jacques: member, Compensation | Source reportedE8 |
| Committee appointment | Robert K. Weigle: member, Compensation | Source reportedE8 |
| Committee appointment | Robert K. Weigle: chair, Nominating and Governance | Source reportedE8 |
| Committee appointment | Ivan Howard: member, Nominating and Governance | Source reportedE8 |
Financial context
2 claims| Fact | Stated value | Evidence |
|---|---|---|
| Security listing | TNON (NASDAQ) | Source reportedE1 |
| Security listing | TNONW (NASDAQ) | Source reportedE1 |
Other published claims
3 claims| Fact | Stated value | Evidence |
|---|---|---|
| Legal name | Tenon Medical, Inc. | Source reportedE1 |
| Entity status | Public listing published | Source reportedE1 |
| Published fact | US | Source reportedE1 |
Evidence
8 evidence records| Ref | Source | Authority | Source date | Retrieved | Rights | Cited by |
|---|---|---|---|---|---|---|
| E1 | Alpha canonical company public projectionCanonical identity | Open web | Not recorded | Rights not recorded, link only | 5 claims | |
| E2 | Tenon Medical, Inc. DEF 14A 2025-06-17SEC proxy | Authoritative, regulatory filing | Rights not recorded, link only | 7 claims | ||
| E3 | TNON 10-K executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E4 | TNON 10-K executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E5 | TNON 10-K executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E6 | TNON 10-K executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E7 | TNON 10-K executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E8 | Auditboard_seats. Board seats | Authoritative, regulatory filing | Not recorded | Not recorded | Rights not recorded, link only | 11 claims |
No evidence record is pinned or signed yet.
Not yet in this record
These parts of a company record have no published claims yet. That is a coverage state, not a finding about the company. 1 further claim is under review.
- Control and voting
- Governance
- Risk
- AI oversight
- Legal
- Compensation
Index memberships
No current membership is published in Alpha's tracked index universe.
This is not evidence that the company is absent from every market index.
As of 22 Nov 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Coverage states the record reports (12)
- Corporate structure
- Not reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- Ownership
- Not reviewed. Ownership and voting power determine who can influence the board.
- Financials
- Not reviewed. Governance-relevant financial context frames capital and audit decisions.
- Compensation
- Not reviewed. Pay design shows how incentives are governed.
- Governance
- Not reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governance
- Not reviewed. Meeting and vote records show shareholder dissent and support.
- Audit
- Not reviewed. Auditor, controls and restatements show assurance over reporting.
- Legal
- Not reviewed. Material legal and regulatory matters show enforcement exposure.
- Risk
- Not reviewed. Risk ownership links the board, committees, executives and controls.
- Cyber
- Not reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governance
- Not reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets external
- Not reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
Limits of this record (5)
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
History
Version public-1Published .
- CFO role recorded. Kevin Williamson executive of Tenon Medical, Inc., effective 27 Mar 2026.Effective . Recorded .
- Executive appointed. Nathaniel Grawey executive of Tenon Medical, Inc., effective 27 Mar 2026.Effective . Recorded .
- Executive appointed. Richard Ginn executive of Tenon Medical, Inc., effective 27 Mar 2026.Effective . Recorded .
- CEO role recorded. Steven M. Foster executive of Tenon Medical, Inc., effective 27 Mar 2026.Effective . Recorded .
- Executive appointed. Wyatt Geist executive of Tenon Medical, Inc., effective 27 Mar 2026.Effective . Recorded .
- Director appointed. Kristine M. Jacques seat on Tenon Medical, Inc., effective 2024.Effective . Recorded .
- Committee created. Audit; Compensation committee of Tenon Medical, Inc., effective 2024.Effective . Recorded .
- Committee member added. Kristine M. Jacques member of Audit; Compensation, effective 2024.Effective . Recorded .
- Director appointed. Ivan Howard seat on Tenon Medical, Inc., effective 2022.Effective . Recorded .
- Director appointed. Robert K. Weigle seat on Tenon Medical, Inc., effective 2022.Effective . Recorded .
- Director appointed. Stephen H. Hochschuler, M.D. seat on Tenon Medical, Inc., effective 2022.Effective . Recorded .
- Committee created. Audit · Chair; Compensation; Nominating and Governance committee of Tenon Medical, Inc., effective 2022.Effective . Recorded .
- Committee member added. Ivan Howard member of Audit · Chair; Compensation; Nominating and Governance, effective 2022.Effective . Recorded .
- Committee created. Audit; Compensation; Nominating and Governance · Chair committee of Tenon Medical, Inc., effective 2022.Effective . Recorded .
- Committee member added. Robert K. Weigle member of Audit; Compensation; Nominating and Governance · Chair, effective 2022.Effective . Recorded .
- Director appointed. Steven M. Foster seat on Tenon Medical, Inc., effective 2021.Effective . Recorded .
- Director appointed. Richard Ferrari seat on Tenon Medical, Inc., effective 2012.Effective . Recorded .
- Director appointed. Richard Ginn seat on Tenon Medical, Inc., effective 2012.Effective . Recorded .
About this record
- Alpha ID
- alpha:company:0345970e-54ff-4a71-94e4-0c69f935d87e
- Version
- public-1:ro-d751713988987e9331980363e24189ce
- Identity
- Not claimed
- Evidence
- Source reported
- Evaluation
- Not assessed
- Monitoring
- Not monitored yet
- Authority
- Not published
- Freshness
- Current
- Integrity
- Not signed yet
- Basis
- Published company record built from public sources
- Never published
- Private company data: deployments, authority grants, TrustChecks, receipts, telemetry
The company can claim this record and correct or dispute any claim. Corrections are versioned and the original stays in history. A company's own statements are shown as its own and never replace the cited evidence.

